Nasdaq Panel Denies OSR Health Continued Listing Request
Nasdaq's Hearings Panel denied OSR Health's request for continued listing on October 23, 2026, and determined to delist its securities after the company failed to meet the minimum bid price requirement. Trading had been suspended since August 26, 2026.